Docetaxel

TNF superfamily member 11 ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24496001 RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. 2014 Mar 1
2 18792431 Re: RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastasis model. 2008 Sep 1
3 16651437 Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. 2006 May 1 2